Legal Status Overview
Gray AreaPeptides are in a legal gray area in Missouri because the state has no statute, administrative rule, or Board of Pharmacy regulation that names 'peptides' or 'research chemicals' as a distinct category. Instead, the Missouri Board of Pharmacy licenses and inspects compounding pharmacies under Chapter 338 RSMo and Title 20 CSR rules that incorporate federal compounding law (FDCA Sections 503A and 503B), so whether a given peptide can be legally dispensed in Missouri depends on FDA approval status and the FDA's compounding bulk-substance lists, not on any Missouri-only rule. Practically, FDA-approved peptide drugs are prescription-only through licensed Missouri prescribers, while unapproved research peptides marketed as 'research use only' fall under ongoing federal enforcement rather than state-specific prohibition.
Key Points
- Missouri has no statute or Missouri Board of Pharmacy rule that specifically names 'peptides' or 'research chemicals' as a distinct regulated category; searches of Missouri Board of Pharmacy statutes, rules, and newsletters found only general compounding and pharmacy-licensure provisions, not peptide-specific language. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- The Missouri Board of Pharmacy regulates compounding pharmacies (Class D non-sterile and Class H sterile compounding permits) under rules that reference and incorporate the federal 503A compounding framework, including the requirement that pharmacies not compound in inordinate amounts for 'office use.' [1]
- The Missouri Board of Pharmacy operates under Chapter 338 RSMo, which grants it rulemaking authority to enforce pharmacy practice standards but does not itself list specific compounds like peptides. [3]
- In Missouri, FDA-approved GLP-1 medications such as semaglutide can be prescribed by an MD, DO, a nurse practitioner with a collaborative practice arrangement, or a physician assistant with a supervising physician, meaning a valid prescriber relationship is required rather than over-the-counter purchase. [5]
- The FDA's Pharmacy Compounding Advisory Committee voted in 2025 to recommend adding BPC-157, TB-500, KPV, MOTS-c, Epitalon, and Semax to the federal 503A bulk drug substances list, a step that would allow licensed compounding pharmacies to use them under a prescription, but this vote is non-binding and has not yet been finalized by the FDA as of the most recent scheduled July 2026 committee meeting. [7]
- Because no FDA rulemaking approving BPC-157 for compounding has been completed, a Pharmacy Compounding Advisory Committee recommendation alone does not make BPC-157 legal to compound or sell for human use anywhere in the United States, including Missouri. [8]
- In September 2025 the FDA issued more than 50 warning letters nationwide to companies selling semaglutide, tirzepatide, retatrutide, BPC-157, and similar peptides under 'research use only' labeling while marketing them for human use, reflecting federal (not Missouri-specific) enforcement pressure on this market. [9]
- There is no known Missouri-specific personal-use or travel exemption allowing residents to buy or bring in unapproved research peptides for personal use; absent a Missouri prescription law addressing peptides directly, buyers rely on the same federal prescription requirements that apply nationwide. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in Missouri
| BPC-157 | BPC-157 is not FDA-approved and is not currently legal to compound or sell for human use in Missouri, since it has not completed the FDA's bulk drug substance rulemaking despite a 2025 nonbinding advisory committee recommendation in its favor. [8] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | FDA-approved semaglutide and tirzepatide products are legal in Missouri only by prescription from a licensed MD, DO, nurse practitioner with a collaborative practice arrangement, or physician assistant with a supervising physician, while non-FDA-approved compounded versions face tightening federal restrictions now that the FDA-declared shortage has ended. [5] |
| TB-500 | TB-500 is an unapproved research peptide that, like BPC-157, was named in the FDA Pharmacy Compounding Advisory Committee's 2025 recommendation for possible future inclusion on the compounding bulk drug list, meaning it remains legally unapproved for human use in Missouri today. [7] |
| Human Growth Hormone (HGH/somatropin) | FDA-approved recombinant human growth hormone (somatropin) products are legal in Missouri only by physician prescription for FDA-approved indications, and federal law makes it illegal to distribute or possess HGH for any other purpose, such as bodybuilding or anti-aging use. [10] |
Sources
Last researched: 2026-09-09
Frequently asked questions
Can I buy peptides in Missouri without a prescription?
No -- in Missouri, FDA-approved peptide drugs like semaglutide, tirzepatide, and somatropin (HGH) legally require a prescription from a licensed Missouri prescriber, and unapproved 'research' peptides such as BPC-157 or TB-500 are not lawfully sold for human consumption regardless of prescription status. [5]
Is BPC-157 legal in Missouri?
BPC-157 is not legal for human use or compounding in Missouri because it lacks FDA approval and has not completed the federal rulemaking needed for inclusion on the compounding bulk drug list, even though an FDA advisory committee recommended it for that list in 2025. [8]
Can I get semaglutide prescribed through telehealth in Missouri?
Yes, in principle -- Missouri allows semaglutide to be prescribed by an MD, DO, a nurse practitioner under a collaborative practice arrangement, or a physician assistant with a supervising physician, and telehealth visits with such a licensed prescriber can lead to a valid prescription, though the exact rules depend on the prescriber's licensure requirements rather than a peptide-specific telehealth statute. [5]
What are the penalties for selling illegal peptides in Missouri?
There is no Missouri-specific peptide penalty statute; enforcement so far has come from the FDA at the federal level, which in September 2025 sent over 50 warning letters to sellers of unapproved peptides like BPC-157 and semaglutide marketed as 'research use only,' a step that can precede federal misbranding or adulteration charges under the FDCA. [9]
Is compounded semaglutide legal at Missouri pharmacies?
Compounded semaglutide can be legal in Missouri only when prepared by a properly licensed 503A or 503B compounding pharmacy under a patient-specific prescription and consistent with Missouri Board of Pharmacy compounding rules, but the FDA has narrowed the shortage-based allowance that previously permitted widespread compounding of semaglutide. [1]